High rates of excessive calorie intake diets and sedentary lifestyles have led to a global increase in nonalcoholic fatty liver disease(NAFLD).As a result,this condition has recently become one of the leading causes o...High rates of excessive calorie intake diets and sedentary lifestyles have led to a global increase in nonalcoholic fatty liver disease(NAFLD).As a result,this condition has recently become one of the leading causes of hepatocellular carcinoma(HCC).Furthermore,the incidence of NAFLD-associated HCC(NAFLD-HCC)is expected to increase in the near future.Advanced liver fibrosis is the most common risk factor for NAFLD-HCC.However,up to 50%of NAFLDHCC cases develop without underlying liver cirrhosis.Epidemiological studies have revealed many other risk factors for this condition;including diabetes,other metabolic traits,obesity,old age,male sex,Hispanic ethnicity,mild alcohol intake,and elevated liver enzymes.Specific gene variants,such as single-nucleotide polymorphisms of patatin-like phospholipase domain 3,transmembrane 6 superfamily member 2,and membrane-bound O-acyl-transferase domaincontaining 7,are also associated with an increased risk of HCC in patients with NAFLD.This clinical and genetic information should be interpreted together for accurate risk prediction.Alpha-fetoprotein(AFP)is the only biomarker currently recommended for HCC screening.However,it is not sufficiently sensitive in addressing this diagnostic challenge.The GALAD score can be calculated based on sex,age,lectin-bound AFP,AFP,and des-carboxyprothrombin and is reported to show better diagnostic performance for HCC.In addition,emerging studies on genetic and epigenetic biomarkers have also yielded promising diagnostic potential.However,further research is needed to establish an effective surveillance program for the early diagnosis of NAFLD-HCC.展开更多
文摘High rates of excessive calorie intake diets and sedentary lifestyles have led to a global increase in nonalcoholic fatty liver disease(NAFLD).As a result,this condition has recently become one of the leading causes of hepatocellular carcinoma(HCC).Furthermore,the incidence of NAFLD-associated HCC(NAFLD-HCC)is expected to increase in the near future.Advanced liver fibrosis is the most common risk factor for NAFLD-HCC.However,up to 50%of NAFLDHCC cases develop without underlying liver cirrhosis.Epidemiological studies have revealed many other risk factors for this condition;including diabetes,other metabolic traits,obesity,old age,male sex,Hispanic ethnicity,mild alcohol intake,and elevated liver enzymes.Specific gene variants,such as single-nucleotide polymorphisms of patatin-like phospholipase domain 3,transmembrane 6 superfamily member 2,and membrane-bound O-acyl-transferase domaincontaining 7,are also associated with an increased risk of HCC in patients with NAFLD.This clinical and genetic information should be interpreted together for accurate risk prediction.Alpha-fetoprotein(AFP)is the only biomarker currently recommended for HCC screening.However,it is not sufficiently sensitive in addressing this diagnostic challenge.The GALAD score can be calculated based on sex,age,lectin-bound AFP,AFP,and des-carboxyprothrombin and is reported to show better diagnostic performance for HCC.In addition,emerging studies on genetic and epigenetic biomarkers have also yielded promising diagnostic potential.However,further research is needed to establish an effective surveillance program for the early diagnosis of NAFLD-HCC.
